Study sets new standard for graft-versus-host disease prevention after stem cell transplant

Clinicians have a new standard for graft-versus-host disease (GVHD) prevention after allogeneic hematopoietic stem cell transplantation, according to results from a phase III study. The new standard is more effective at preventing GVHD and came with less side effects, compared with the current gold standard.

from Top Health News -- ScienceDaily https://ift.tt/mIASzK7